Announcement on Conducting Foreign Exchange Derivatives Trading Business
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Conducting Foreign Exchange Derivatives Trading Business
Filed with SSE · · 4 pages · Chinese
Release
Frontier Biotechnologies Inc. on 6ix
Earlier from Frontier Biotechnologies
- Announcement on Change of Scheduled Disclosure Time for Periodic Reports
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of FB7013 Injection
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on the Signing of an Authorization and License Agreement with GSK
- Earnings Preannouncement for 2025
Later from Frontier Biotechnologies
- Announcement on Changing the Disclosure Time of 2025 Annual Report and Report for Q1 2026
- Correction Announcement on Preliminary Earnings Estimate for 2025 and Earnings Preannouncement
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Reply to the Supervision and Inquiry Letter Regarding Information Disclosure of the 2025 Annual Report
- Announcement on Abnormal Fluctuations in Stock Trading
Follow Frontier Biotechnologies into a list and get an email when it puts out news.
Follow Frontier Biotechnologies